Background and Objectives The aims of this multi‐institutional study were to assess the
feasibility of iterative cytoreductive surgery (iCRS)/hyperthermic intraperitoneal …

Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) are currently the most accepted treatment for peritoneal metastases from colorectal …

Colorectal peritoneal metastases (CPM) are associated with abbreviated survival and
significantly impaired quality of life. In patients with CPM, radical multimodality treatment …

Background and Objectives Morbidity after cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy (CRS+ HIPEC) for colorectal peritoneal carcinomatosis (PC) …

Background Although some preclinical studies have inferred that laparoscopic surgery for
advanced cancer may increase the risk of peritoneal metastasis, this potential hazard has …

Background Distant CRC metastasis develops from either hematogenous dissemination or
direct seeding of the peritoneal space. Metastasis is a complex process that involves cellular …

Introduction The optimal treatment for peritoneal carcinomatosis (PC) of colorectal origin is a
combination of cytoreductive surgery and intraperitoneal chemotherapy (CRS+ IPC) …

Background: Patients with intestinal cancer (colorectal, appendiceal, and small bowel) with
peritoneal metastases (PM) have a poor prognosis. We assessed whether pressurized …

The advent of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) changed dramatically the approach to peritoneal surface malignancies (PSM). The …

Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) is becoming accepted treatment for peritoneal carcinomatosis (PC) from colorectal …